News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Nvidia Plunges Overnight: Institutions Sell Off, Retail Investors Rush to Buy?
华尔街见闻·2026/02/27 00:32

Luckin: Has the Delivery War "Hijacked" the Top Coffee Brand?
海豚投研·2026/02/27 00:30

鲍威尔鹰派讲话重创降息预期,全球市场直面“新风暴”!
moomoo-证劵·2026/02/27 00:27
Analysts reject Jane Street 10am Bitcoin dump
Grafa·2026/02/27 00:27
Suspects Arrested After South Korean Police Mishandle $1.4 Million in Bitcoin: Report
Decrypt·2026/02/27 00:17

Aptos eyes $1 again: Can Decibel upgrade sustain APT’s rally?
AMBCrypto·2026/02/27 00:03
Vitalik Buterin Maps Quantum Upgrade to Ethereum to Replace Core Cryptography
Decrypt·2026/02/27 00:00
Shiba Inu (SHIB) Price Outlook for the End of Q1 2026
TimesTabloid·2026/02/27 00:00


Why is Bitcoin’s ‘MOAR’ narrative heating up? ETFs, whales & more…
AMBCrypto·2026/02/26 23:30
Flash
14:37
Ventuals: HIP-3DEX Fully Closed, vHYPE Withdrawal Now AvailableBlockBeats News, June 19th, Ventuals announced that HIP-3 DEX has been fully shut down, and vHYPE withdrawals have now begun. Approximately 380,775 HYPE in the full withdrawal queue was processed around 10 a.m. EST today. Previously queued vHYPE withdrawals were all included in this batch processing.
Ventuals advised all vHYPE holders to initiate withdrawals, stating that 100% of vHYPE holders can redeem their HYPE at a 1:1 ratio and receive accrued native staking rewards since deposit.
14:36
Economist: Spending in Canada shows significant weakness excluding cars and gasolineJasleen Trehan, an economist at the Canadian Chamber of Commerce, stated that Canadians' spending on daily categories such as groceries and general merchandise weakened significantly in April. Nominal retail sales grew by 0.5% in April, but core sales excluding autos and gasoline declined by 0.7%. Trehan said that the estimated growth for May shows signs of consumer resilience, but given the weakness in the labor market, lingering uncertainty over U.S. trade policy, and concerns about energy-driven inflation, the path ahead remains uncertain.
14:33
According to the Financial Times, ongoing negotiations reveal that pharmaceutical giant AbbVie plans to acquire shareholders' equity in biotech company Apogee Therapeutics for a total of $10.9 billion in cash.If this move is ultimately implemented, it will mark AbbVie's further strengthening of its presence in the innovative biologics sector beyond its core immunology field. Market analysts point out that this potential massive deal highlights large pharmaceutical companies’ strong desire to acquire biotech firms with promising pipelines, aiming to supplement their own product portfolios and drive future growth. Currently, neither party has formally commented on the transaction details, and subsequent developments are worth close attention.
News